Can this Shot Cure PTSD? ‘The God Shot’ & Stellate Ganglion Block w/ Dr Eugene Lipov | Mike Drop 218October 22, 2026
Iran Says 7 Oil Tankers Attacked in the Strait of Hormuz as Fears Grow of a Return to WarOctober 22, 2026
Lucas Q. Martin on October 22, 2026 2:03 pm Exploration results look promising, but permitting will be the key risk. Reply
Emma J. Jones on October 22, 2026 2:04 pm Silver leverage is strong here; beta cuts both ways though. Reply
Isabella Jackson on October 22, 2026 2:05 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
Amelia Lopez on October 22, 2026 2:06 pm Interesting update on Navy Trauma Nurse Jab Lab Co-Owner Nikki Selby. Curious how the grades will trend next quarter. Reply
James Martin on October 22, 2026 2:07 pm I like the balance sheet here—less leverage than peers. Reply
William Smith on October 22, 2026 2:07 pm I like the balance sheet here—less leverage than peers. Reply
Oliver Jones on October 22, 2026 2:09 pm Interesting update on Navy Trauma Nurse Jab Lab Co-Owner Nikki Selby. Curious how the grades will trend next quarter. Reply
Patricia K. Martinez on October 22, 2026 3:04 pm Good point. Watching costs and grades closely. Reply
Mary Johnson on October 22, 2026 2:09 pm Nice to see insider buying—usually a good signal in this space. Reply
Michael Davis on October 22, 2026 2:10 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
Oliver Thomas on October 22, 2026 2:11 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
Mary Williams on October 22, 2026 2:12 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Mary U. Davis on October 22, 2026 2:13 pm Silver leverage is strong here; beta cuts both ways though. Reply
Jennifer Thomas on October 22, 2026 2:13 pm I like the balance sheet here—less leverage than peers. Reply
Robert Miller on October 22, 2026 2:13 pm If AISC keeps dropping, this becomes investable for me. Reply
By Mike Ritland
By Mike Ritland
By Mike Ritland
31 Comments
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Navy Trauma Nurse Jab Lab Co-Owner Nikki Selby. Curious how the grades will trend next quarter.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Interesting update on Navy Trauma Nurse Jab Lab Co-Owner Nikki Selby. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
I like the balance sheet here—less leverage than peers.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.